Cellbank Inc. Partners with The Plus Plastic Surgery Daikanyama to Offer Cultured Dermal Fibroblast Cells for Skin Regeneration Therapy

Cellbank Inc. (Location: Chuo-ku, Tokyo; Representative Director: Genji Hojo; hereinafter "the Company"), which operates a specified cell processing business, has partnered with The Plus Plastic Surgery Daikanyama (Location: Shibuya-ku, Tokyo; Director: Daikan Ike) as a partner medical institution, and has commenced the provision of autologous cultured dermal fibroblasts for skin regeneration therapy (hereinafter "regenerative medicine for skin"). The Plus Plastic Surgery, with branches in Korea, Tokyo, and Nagoya, is a technology-driven clinic staffed exclusively by board-certified specialists of the Japan Society of Plastic and Reconstructive Surgery. They aim to provide high-quality cosmetic medicine by fusing advanced techniques recognized in domestic and international academic societies with active technical exchange between Japan and Korea, incorporating widely acclaimed Asian technologies and trends.

Services and Products Offered https://cellbank.co.jp/hcps/safety_qualitycontrol/

About Cellbank

The Company was founded in 2004 and has been providing cells since before "regenerative medicine" was widely recognized. In accordance with the "Act on the Safety of Regenerative Medicine, etc." enacted in 2014, the Company obtained a license for manufacturing specified cell-processed products from the Ministry of Health, Labour and Welfare in 2015.

With a large-scale cell culture processing facility (CPC) of approximately 300m2, the Company manufactures and stores cell products. It provides contract manufacturing services for over 100 medical institutions nationwide offering regenerative medicine for skin (cosmetic field) and regenerative medicine for knees (orthopedic field), performing over 5,000 cultures annually. (As of January 2026).

Leveraging our technological expertise, which includes support for implementation in medical institutions nationwide and over 20 years of cell storage experience, we will provide comprehensive support to our partner medical institutions, including operational aspects.

Skin Regeneration Therapy Using One's Own Cells as Medical Treatment

― Regenerative Medicine for Skin ―

Regenerative medicine aims to restore lost functions and tissues in the body using cells. Within this field, regenerative medicine for skin is a cosmetic therapy that involves culturing one's own dermal fibroblasts and transplanting them into areas of the skin where cell count has decreased. Dermal fibroblasts produce collagen, hyaluronic acid, and elastin, which maintain skin elasticity and moisture. By transplanting and increasing dermal fibroblasts, which decrease with age, symptoms such as wrinkles and sagging can be improved. Furthermore, as this treatment aims to "restore the state where cells originally existed" by supplementing one's own cells, the effects are natural. Additionally, by linking with our "cell storage" service, where dermal fibroblasts are cryopreserved and thawed for use at the desired time of transplantation, one can store their current dermal fibroblasts for future use and undergo regular transplantation.

Medical institutions are required to establish advanced systems for cell processing, quality control, and legal compliance to provide regenerative medicine safely and continuously. In this partnership, Cellbank Inc., as a manufacturer of specified cell-processed products, will be responsible for cell processing, quality control, and supply, supporting the creation of an environment where medical institutions can focus on treatment. We will continue to promote the proper dissemination of regenerative medicine and contribute to the improvement of patients' QOL through collaboration with our partner medical institutions.

The Plus Plastic Surgery Daikanyama

150-0033

ROOB1 Daikanyama 3F, 28-13 Sarugaku-cho, Shibuya-ku, Tokyo

Director: Daikan Ike

URL https://theplustokyo.jp/

Services: Plastic and Reconstructive Surgery, Cosmetic Surgery

Cellbank Inc.

104-0054

Inui Building Kachidoki 3-4F, 1-13-1 Kachidoki, Chuo-ku, Tokyo

Representative: Representative Director Genji Hojo

URL https://cellbank.co.jp/

Business Activities: Specified Cell Processing Business, Cell Storage Business, Regenerative Medicine Support Business

Inquiries Regarding This Matter

Cellbank Inc.

Department: Corporate Planning Department

Phone Number: 03-5547-0207

Email: info@cellbank.co.jp